pI7L suppresses the IFN-γ-triggered JAK-STAT signaling pathway. by Meilin Li (1832905)

The <i>I7L</i> gene is involved in ASFV pathogenicity in pigs. by Meilin Li (1832905)

Methodological workflow used in the study. by Ajit Kumar Rudra (21647706)

“…From the analysis it was observed that the forest cover showed a major variation with the interval, decreasing from 234634 ha (76%) in 1988 to 168476 ha (54%) in 2019 with an annual loss of 2134.13 ha/year. …”

Measurements of body mass index (BMI) and adipose deposits. by Jessica C. M. Hui (20370522)

Loss of FAT1 expression results in increased YAP/TAZ protein levels. by Rui Li (4631)

Analysis of Tregs from perinatal mice and mixed BM chimeras for transitional and terminal eTreg states. by Erienne G. Norton (9612079)

Quantification of fasting glucose, random glucose, and insulin levels. by Jessica C. M. Hui (20370522)

E3 ligase TRIM56 is up-regulated in response to CVB3 infection. by Yao Wang (102387)

The biological characteristics of the I7L protein (pI7L). by Meilin Li (1832905)

FAT1 interacts with the E3 ligase MIB2. by Rui Li (4631)

Effect of <i>CrBV3-31</i> interference on lipid metabolism in FAW larvae. by Xian Li (201841)

Targeting of Vps34 reduces B16F10 tumor growth and working model for Vps34-dependent regulation of eTreg transitional heterogeneity and maintenance. by Erienne G. Norton (9612079)

FAT1 and MIB2 control tumor growth <i>in vivo.</i> by Rui Li (4631)

<i>Cyc</i> downregulation in circadian pacemaker neurons prevents the formation of sLN_vs axon bundles. by Grace Biondi (19924067)

pI7L suppresses the IFN-<i>γ</i>-triggered JAK-STAT signaling pathway. by Meilin Li (1832905)

pI7L inhibits the phosphorylation of STAT1 depending on its tyrosine at position 98. by Meilin Li (1832905)

Effect of <i>CrBV3-31</i> interference on the performance of <i>Cotesia ruficrus</i> offspring. by Xian Li (201841)

TRIM56 promotes the ubiquitination and proteasomal degradation of CVB3 3D. by Yao Wang (102387)

Uvrag in Tregs is dispensable for establishment of immune tolerance and eTreg accumulation. by Erienne G. Norton (9612079)

Targeting of Vps34 or Atg14, but not Uvrag, in Tregs reduces tumor growth in mouse models. by Erienne G. Norton (9612079)